Neuronetics, Inc. — Form SCHEDULE 13D/A
Filed November 16, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
▼ Likely negative
significance 76/100
What the filing says
Between 10/30/2026 and 11/13/2026, an identified reporting person executed a net sale of approximately 8,515,362 shares of Neuronetics common stock. Share prices declined sharply from $2.27 (10/30) to $1.16 (11/13), a 49% drop. The largest single transaction was a sale of 7.4M shares on 11/13/2026 at $1.16/share, suggesting either forced liquidation or a major shareholder exit.
Why this rating
8.5M shares at $1.43 average ≈ $12.2M proceeds—9.4% of company market cap. Massive share dump + stock collapse signals loss of confidence or distress. Material for $129M company.
Tradability signal
NO TRADE
No trade: negative news, but this cell's evidence is too weak. Similar past filings (342 in this cell) moved -1.08% in the called direction over 4 hrs; shrunk for sample size that's a -1.00% edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
at our read · unknown $1.39 | +10 min · unknown $1.38 ▼ 0.79% | +30 min · unknown $1.32 ▼ 4.74% | +1 hr · unknown $1.32 ▼ 5.10% | +4 hrs · unknown $1.28 ▼ 7.98% |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.